Entero Therapeutics Inc
Research Entero Therapeutics Inc (GRDX) on Bullrun: market cap USD 34.36M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerGRDX
- ExchangeNASDAQ
- CountryUnited Kingdom
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 34.36M
- Financial periodQ2 2026
- RevenueUSD 85.88K
- Net income-USD 12.82M
- Free cash flow-USD 1.50M
- Gross margin-42.5%
Valuation Snapshot
latest market cap is USD 34.36M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 36.25K | -USD 6.39M | -USD 5.70M | -1813.6% | -4.16 | USD 899.78K | USD 2.26M | USD 24.94M |
| FY2024 | USD 0 | -USD 18.06M | -USD 9.22M | n/a | -15.99 | USD 163.48K | USD 140.53K | -USD 3.88M |
| FY2023 | USD 0 | -USD 15.79M | -USD 12.88M | n/a | -47.88 | USD 3.71M | USD 826.84K | USD 3.60M |
| FY2022 | USD 0 | -USD 14.63M | -USD 22.34M | n/a | -416.94 | USD 1.36M | USD 883.71K | USD 2.74M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 34.36M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 15.67M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 2.96M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 6.56M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 5.08M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 21.85M | n/a | n/a | n/a |
About Entero Therapeutics Inc
GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Entero Therapeutics Inc's market cap?
Entero Therapeutics Inc's market capitalization is USD 34.36M.
What does Entero Therapeutics Inc do?
GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.